glp-1 reimbursement news The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Alarming rise in weight loss

The drug has completed four Phase 1 trials in adults with brain, breast, and skin cancers and received FDA Fast Track designation for pediatric central nervous system tumors

In fact, taking it on a completely empty stomach might actually make you feel a bit more lightheaded or nauseous

Ozempic not only helps control blood sugar in people with type 2 diabetes, but many patients also experience weight loss as a beneficial side effect

The industry is expected to grow at a CAGR of 12.2% from 2025 to 2035

If you're losing weight too rapidly or feeling weak, consult your healthcare provider

New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss A new real-world study presented at the ASMBS 2025 Annual Meeting compares outcomes between GLP-1 medications (such as semaglutide and tirzepatide) and bariatric surgery